• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICSAFE MEDICAL GROUP (CHINA) CO. INC. RELI BLUNT FILL NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICSAFE MEDICAL GROUP (CHINA) CO. INC. RELI BLUNT FILL NEEDLE Back to Search Results
Model Number BFN18G151
Device Problem Contamination (1120)
Patient Problem No Patient Involvement (2645)
Event Date 08/07/2019
Event Type  malfunction  
Event Description
It was reported that the rn drew up solu-medrol from a vial into a 3cc syringe using the blunt fill needle.Rn noticed a sliver of red material which appears to be a piece of the stopper floating in the fluid in the syringe.The medication was not administered to the patient.
 
Event Description
It was reported that the rn drew up solu-medrol from a vial into a 3cc syringe using the blunt fill needle.Rn noticed a sliver of red material which appears to be a piece of the stopper floating in the fluid in the syringe.The medication was not administered to the patient.
 
Manufacturer Narrative
Coring testing was completed on retained samples from the same batch and no coring was observed.The test was conducted using the company test protocol in accordance with iso 7864 and using us sourced test vials.The retained batch samples were compared to the returned suspect defect sample under magnification for any visible defect in the cutting edge of and no defects to either the returned sample or the retain batch samples were observed.All met specification for the magnification check.Dhr and raw material records for the lot were audited and found to be in order; no changes were made to approved specifications.Based on their investigation, the manufacturer concludes needle quality was not the root cause.
 
Manufacturer Narrative
Coring testing was completed on retained samples from the same batch and no coring was observed.The test was conducted using the company test protocol in accordance with iso 7864 and using us sourced test vials.The retained batch samples were compared to the returned suspect defect sample under magnification for any visible defect in the cutting edge of and no defects to either the returned sample or the retain batch samples were observed.All met specification for the magnification check.Dhr and raw material records for the lot were audited and found to be in order; no changes were made to approved specifications.Based on their investigation, the manufacturer concludes needle quality was not the root cause.Additional narrative: no further action will be taken by the manufacturer as the product met specification and no root cause was determined.Both the distributor customer and end-user facility have been notified of the complaint file closure.We consider this file to be closed.
 
Event Description
It was reported that the rn drew up solu-medrol from a vial into a 3cc syringe using the blunt fill needle.Rn noticed a sliver of red material which appears to be a piece of the stopper floating in the fluid in the syringe.The medication was not administered to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RELI BLUNT FILL NEEDLE
Type of Device
BLUNT FILL NEEDLE
Manufacturer (Section D)
MICSAFE MEDICAL GROUP (CHINA) CO. INC.
802-805, building 6
no.1678 jingshajiang rd.
shanghai, 20033 3
CH  200333
MDR Report Key8900924
MDR Text Key154553114
Report Number1058382-2019-00004
Device Sequence Number1
Product Code GAA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup,Followup
Report Date 08/16/2019,09/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/15/2024
Device Model NumberBFN18G151
Device Lot Number190415
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/16/2019
Was the Report Sent to FDA? Yes
Date Report Sent to FDA08/16/2019
Distributor Facility Aware Date08/08/2019
Device Age6 MO
Event Location Hospital
Date Report to Manufacturer08/08/2019
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/16/2019
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received09/05/2019
09/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-